Clinical trial
Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
NCT00181987 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181987 |
|---|---|
| Title | Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder |
| Official title | Open-Label Study of Concerta in the Treatment of ADHD in Youth and Adults With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ADHD, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | methylphenidate HCl (Concerta) |
| Enrollment | 29 |
| Start date | Aug 1, 2002 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: